Stem Cell Research

It seems to me that any stem cell samples derived from human tissue that were acquired prior to the current debate1,2,3 on the ethics and fundability of such work should be destroyed and not used for research. It is [possible] that such samples were not acquired with consent forms that described this type of work and its scope as fully as necessary. Or more correctly, if such consent was not properly outlined, then those samples should be destroyed, as the donors were not properly informed. Th

Written byNancy Piotrowski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

It seems to me that any stem cell samples derived from human tissue that were acquired prior to the current debate1,2,3 on the ethics and fundability of such work should be destroyed and not used for research. It is [possible] that such samples were not acquired with consent forms that described this type of work and its scope as fully as necessary. Or more correctly, if such consent was not properly outlined, then those samples should be destroyed, as the donors were not properly informed.

The right of individuals to control, via an informed decision, what happens to their body, organs, bodily tissue, and genetic material, even after it has been collected from them, remains their right.

To assume that because the materials would only otherwise be destroyed that they were "up for grabs" for research purposes is not valid.

I hope the current debate on stem cell funding will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies